Why Investors Should Favor Smaller Biotech Companies thestreet.com/investing/stoc…
Biotech-Insider retweeted
Potential DNA damage from #CRISPR has been ‘seriously underestimated,’ study finds statnews.com/2018/07/16/cris… via @statnews #NBTintheNews
2018 Is a Hot Year for Biotech Startups, IPOs and M&A Activity
biospace.com/article/2018-is…
3 Biotech Stocks With Major Potential Catalysts in July
fool.com/investing/2018/06/2…
Here Comes The Next Biotech Revolution
seekingalpha.com/article/418…
2 Clinical-Stage Biotech Stocks That Could Soar Next Week fool.com/investing/2018/06/1…
After a pullback $GWPH may have caught support at its 50-day at $149.25. Could it be setting up for a rally into FDA news?




